These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9094984)

  • 41. Expression of the antimicrobial peptide, human beta-defensin 1, in duct cells of minor salivary glands and detection in saliva.
    Sahasrabudhe KS; Kimball JR; Morton TH; Weinberg A; Dale BA
    J Dent Res; 2000 Sep; 79(9):1669-74. PubMed ID: 11023262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role.
    King AE; Critchley HO; Kelly RW
    Mol Hum Reprod; 2000 Feb; 6(2):191-6. PubMed ID: 10655462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secretory leukocyte protease inhibitor is a novel inhibitor of fibroblast-mediated collagen gel contraction.
    Sumi Y; Muramatsu H; Hata K; Ueda M; Muramatsu T
    Exp Cell Res; 2000 Apr; 256(1):203-12. PubMed ID: 10739667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization.
    Ohlsson K; Bjartell A; Lilja H
    J Androl; 1995; 16(1):64-74. PubMed ID: 7539415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV inhibitor identified in saliva.
    Marino D
    Dent Today; 1995 Mar; 14(3):22, 26-7. PubMed ID: 9540536
    [No Abstract]   [Full Text] [Related]  

  • 46. Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis.
    Taichman NS; Cruchley AT; Fletcher LM; Hagi-Pavli EP; Paleolog EM; Abrams WR; Booth V; Edwards RM; Malamud D
    Lab Invest; 1998 Jul; 78(7):869-75. PubMed ID: 9690564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The anti-HIV-1 activity associated with saliva.
    Shine N; Konopka K; Düzgüneş N
    J Dent Res; 1997 Feb; 76(2):634-40. PubMed ID: 9062556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral mucosal immunity and HIV infection: current status.
    Challacombe SJ; Sweet SP
    Oral Dis; 2002; 8 Suppl 2():55-62. PubMed ID: 12164661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
    Pierce Campbell CM; Giuliano AR; Torres BN; O'Keefe MT; Ingles DJ; Anderson RL; Teras LR; Gapstur SM
    Oral Oncol; 2016 Apr; 55():1-5. PubMed ID: 27016010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistolocalization and gene expression of the secretory carbonic anhydrase isozymes (CA-VI) in canine oral mucosa, salivary glands and oesophagus.
    Kasuya T; Shibata S; Kaseda M; Ichihara N; Nishita T; Murakami M; Asari M
    Anat Histol Embryol; 2007 Feb; 36(1):53-7. PubMed ID: 17266669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
    Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
    Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased serum concentrations of secretory leukoprotease inhibitor in patients with primary Sjögren's syndrome.
    Maruyama M; Sugiyama E; Hori T; Murayama R; Nakazaki S; Yamashita N; Kobayashi M
    In Vivo; 1998; 12(5):535-8. PubMed ID: 9827363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle.
    Moriyama A; Shimoya K; Ogata I; Kimura T; Nakamura T; Wada H; Ohashi K; Azuma C; Saji F; Murata Y
    Mol Hum Reprod; 1999 Jul; 5(7):656-61. PubMed ID: 10381821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human submandibular saliva specifically inhibits HIV type 1.
    Nagashunmugam T; Friedman HM; Davis C; Kennedy S; Goldstein LT; Malamud D
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):371-6. PubMed ID: 9075477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva.
    Murakami M; Ohtake T; Dorschner RA; Gallo RL
    J Dent Res; 2002 Dec; 81(12):845-50. PubMed ID: 12454100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission.
    Pillay K; Coutsoudis A; Agadzi-Naqvi AK; Kuhn L; Coovadia HM; Janoff EN
    J Infect Dis; 2001 Feb; 183(4):653-6. PubMed ID: 11170993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of the secretory leucocyte proteinase inhibitor in human articular cartilage.
    Ohlsson S; Tufvesson B; Polling A; Ohlsson K
    Biol Chem; 1997 Sep; 378(9):1055-8. PubMed ID: 9348116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.
    Nyström M; Bergenfeldt M; Ljungcrantz I; Lindeheim A; Ohlsson K
    Mediators Inflamm; 1999; 8(3):147-51. PubMed ID: 10704052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Inhibitory effect of human saliva on HIV-1 infectivity].
    Etsuko K; Wei S
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Aug; 24(4):152-9. PubMed ID: 16578966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.